Shenouda Maged

Avg. Two Year Performance

(34%) Avg. Purchase Return
(16%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return29%50%28%(8%)(34%)
Purchase Success Rate2 of 32 of 32 of 31 of 30 of 3
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Entero Therapeutics, Inc.

Other » Other

CHIEF FINANCIAL OFFICER, Director:

Holdings: 62.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Relmada Therapeutics, Inc.

Drugs » Drugs - Generic

Chief Financial Officer:

Holdings: 88.33K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Protea Biosciences Group, I...

Other » Other

Director:

Holdings: 100.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--